SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
-----------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 26, 2002
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
------------------------------------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 0-26224 51-0317849
--------------------------- ------------ -------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
311 ENTERPRISE DRIVE
PLAINSBORO, NEW JERSEY 08536
--------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number,
including area code: (609) 275-0500
--------------
NOT APPLICABLE
--------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
1
Item 5. Other Events
On February 26, 2002, the Company's Board of Directors reauthorized the
Company's share repurchase program. Under the program, the Company may
repurchase up to 500,000 shares of its common stock for an aggregate purchase
price not to exceed $15 million. Shares may be repurchased under this program
through December 31, 2002 either in the open market or privately negotiated
transactions.
The Company did not repurchase any shares of its common stock under this program
in 2001.
Item 7. Exhibits
None
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
INTEGRA LIFESCIENCES HOLDINGS
CORPORATION
Date: March 13, 2002 By: /s/ Stuart M. Essig
-----------------------------------
Stuart M. Essig, President and
Chief Executive Officer
2